start

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-03-15T17:14:50+00:00

Clinical Pharmacology Reference PharmAtlas by Andrew Overholser, DMSc, PA Pharmacology is best learned through mechanism → physiology → therapeutics. This reference mirrors real prescribing decisions: understand signaling → apply it to organ systems → manage complex disease.

chlorthalidone - Create Chlorthalidone page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:05:10+00:00

====== Chlorthalidone (Hygroton®) ====== | | |^ Chlorthalidone || Brand Names | Hygroton® || Drug Class | Thiazide-Like Diuretic || Primary Indications | Hypertension; Edema || Blood Pressure Effect | ↓ BP (chronic) || Mortality Benefit | No (BP control) || Elimination | Renal || Black Box Warning | No || FDA Approval | 1960 |

bumetanide - Create Bumetanide page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:05:04+00:00

====== Bumetanide (Bumex®) ====== | | |^ Bumetanide || Brand Names | Bumex® || Drug Class | Loop Diuretic || Primary Indications | Heart Failure; Edema; CKD volume overload || Blood Pressure Effect | ↓ preload, ↓ BP || Mortality Benefit | No (symptom relief) || Elimination | Hepatic & renal || Black Box Warning | Ototoxicity (high dose/rapid IV) || FDA Approval | 1983 |

torsemide - Create Torsemide page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:04:59+00:00

====== Torsemide (Demadex®) ====== | | |^ Torsemide || Brand Names | Demadex® || Drug Class | Loop Diuretic || Primary Indications | Heart Failure; Edema; Hypertension (selected) || Blood Pressure Effect | ↓ preload, ↓ BP || Mortality Benefit | No (symptom relief) || Elimination | Hepatic & renal || Black Box Warning | Ototoxicity (high dose/rapid IV) || FDA Approval | 1993 |

hydrochlorothiazide - Create Hydrochlorothiazide page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:02:47+00:00

====== Hydrochlorothiazide (HCTZ®) ====== | | |^ Hydrochlorothiazide || Brand Names | HCTZ® || Drug Class | Thiazide Diuretic || Primary Indications | Hypertension; Mild edema || Blood Pressure Effect | ↓ BP (chronic) || Mortality Benefit | No (BP control) || Elimination | Renal || Black Box Warning | No || FDA Approval | 1959 |

furosemide - Create Furosemide page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:02:42+00:00

====== Furosemide (Lasix®) ====== | | |^ Furosemide || Brand Names | Lasix® || Drug Class | Loop Diuretic || Primary Indications | Heart Failure; Pulmonary edema; Volume overload; CKD edema || Blood Pressure Effect | ↓ preload, ↓ BP || Mortality Benefit | No (symptom relief) || Elimination | Renal || Black Box Warning | Ototoxicity (high dose/rapid IV) || FDA Approval | 1966 |

acetazolamide - Create Acetazolamide page

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:02:36+00:00

====== Acetazolamide (Diamox®) ====== | | |^ Acetazolamide || Brand Names | Diamox® || Drug Class | Carbonic Anhydrase Inhibitor || Primary Indications | Glaucoma; Altitude sickness; Metabolic alkalosis; Idiopathic intracranial hypertension || Blood Pressure Effect | Mild ↓ BP || Mortality Benefit | No || Elimination | Renal || Black Box Warning | No || FDA Approval | 1954 |

drug - Restore master drug template

wilkie (wilkie@undisclosed.example.com) — 2026-03-15T17:00:37+00:00

====== Lisinopril (Prinivil®, Zestril®) ====== | | |^ Lisinopril || Brand Names | Prinivil®, Zestril® || Drug Class | ACE Inhibitor || Primary Indications | Hypertension; Heart Failure (HFrEF); Post-MI || Blood Pressure Effect | ↓ SVR || Mortality Benefit | Yes (HFrEF, post-MI) || Elimination | Renal || Black Box Warning | Fetal Toxicity || FDA Approval | 1987 |

start - Format rheumatology & immunosuppressants landing page

wilkie (wilkie@undisclosed.example.com) — 2026-03-13T22:43:54+00:00

====== Rheumatology & Immunosuppressants ======Inflammatory & autoimmune disease pharmacology This section organizes therapy by immune pathway -> drug class -> clinical use.Start with foundations, then move through drug classes and disease-specific pathways.

start - Create Immunosuppressants landing page

wilkie (wilkie@undisclosed.example.com) — 2026-03-13T21:22:55+00:00

====== Immunosuppressants ======Organized by mechanism, target, and clinical use This section covers systemic immunosuppressive therapies across specialties(rheumatology, transplant, dermatology, GI, nephrology, neurology). ----===== Core Classes ========= Conventional / Antimetabolites ==== *

vitmains.png - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-16T01:37:37+00:00

inflammation.png - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T17:37:26+00:00

psych_med_potencies_for_receptors.pdf - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T15:47:38+00:00

albuterol-teaser.png - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T15:02:44+00:00

levosalbutamol.svg - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T15:01:12+00:00

albuterol-teaser.png - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T14:59:20+00:00

furosemide.svg - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T03:26:19+00:00

chlortalidone.svg - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T03:22:41+00:00

hydrochlorothiazide.svg - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T03:19:46+00:00

esmolol_structure.svg - created

andrew2393cns (andrew2393cns@undisclosed.example.com) — 2026-02-15T03:16:04+00:00